Vogt-Koyanagi-Harada Disease in a Patient with Extreme Anisometropia

Overview

Journal Am J Ophthalmol Case Rep

Specialty Ophthalmology

Date 2023 Sep 29

PMID 37771387

Authors

Marina Maehira

Ayano Oshiro

Naoya Imanaga

Yukihide Yamauchi

Hideki Koizumi

Affiliations

Soon will be listed here.

Abstract

Purpose: To report Vogt-Koyanagi-Harada (VKH) disease in a patient with extreme anisometropia.

Observations: A 56-year-old woman was referred to our hospital. Her past medical history was significant for amblyopia in the right eye. At the initial visit, decimal best-corrected visual acuity (BCVA) was 0.03 (Snellen equivalent 5/160) in the right eye and 0.03 (Snellen equivalent 5/160) in the left eye, and axial length was 28.44 mm and 22.36 mm, respectively. Anterior chamber inflammation was seen predominantly in the right eye with fibrin exudates. Swept-source optical coherence tomography demonstrated choroidal thickening and folds predominantly in the left eye. Additionally, serous retinal detachment (SRD) was much more evident in the left eye than in the right eye. Subfoveal choroidal thickness (SCT) was 417 μm in the right and over 800 μm in the left eye. Cerebrospinal fluid examination revealed lymphocyte-dominant hypercellularity. Based on these findings, we diagnosed the patient with VKH disease and treated her with a high-dose systemic corticosteroid. One month after the initiation of treatment, SRD in both eyes fully resolved, and SCT decreased to 105 μm in the right and 311 μm in the left eye.

Conclusions And Importance: The marked discrepancy in axial length between the right and left eyes might contribute to the different severity of inflammation in VKH disease.

Citing Articles

Association between axial length and uveitis.

Ogawa M, Usui Y, Tsubota K, Goto H Graefes Arch Clin Exp Ophthalmol. 2024; .

PMID: 39419841 DOI: 10.1007/s00417-024-06655-y.

References

Rubsamen P, GASS J . Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol. 1991; 109(5):682-7. DOI: 10.1001/archopht.1991.01080050096037. View

Huang Y, Yang Y, Lin B, Huang S, Sun Z, Zhou R . Melanin change of retinal pigment epithelium and choroid in the convalescent stage of Vogt-Koyanagi-Harada disease. Int J Ophthalmol. 2020; 13(12):1928-1932. PMC: 7708368. DOI: 10.18240/ijo.2020.12.13. View

Miura M, Makita S, Yasuno Y, Tsukahara R, Usui Y, Rao N . Polarization-Sensitive Optical Coherence Tomographic Documentation of Choroidal Melanin Loss in Chronic Vogt-Koyanagi-Harada Disease. Invest Ophthalmol Vis Sci. 2017; 58(11):4467-4476. DOI: 10.1167/iovs.17-22117. View

Sonoda S, Sakamoto T, Yamashita T, Uchino E, Kawano H, Yoshihara N . Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images. Am J Ophthalmol. 2015; 159(6):1123-1131.e1. DOI: 10.1016/j.ajo.2015.03.005. View

Wu H, Zhang G, Shen M, Xu R, Wang P, Guan Z . Assessment of Choroidal Vascularity and Choriocapillaris Blood Perfusion in Anisomyopic Adults by SS-OCT/OCTA. Invest Ophthalmol Vis Sci. 2021; 62(1):8. PMC: 7797932. DOI: 10.1167/iovs.62.1.8. View

Harimoto A, Obata R, Yamamoto M, Aoki N, Yamanari M, Sugiyama S . Retinal pigment epithelium melanin distribution estimated by polarisation entropy and its association with retinal sensitivity in patients with high myopia. Br J Ophthalmol. 2021; 106(10):1457-1462. DOI: 10.1136/bjophthalmol-2021-318890. View

Fernandez-Vigo J, Shi H, Kudsieh B, Arriola-Villalobos P, De-Pablo Gomez-de-Liano L, Garcia-Feijoo J . Ciliary muscle dimensions by swept-source optical coherence tomography and correlation study in a large population. Acta Ophthalmol. 2019; 98(4):e487-e494. DOI: 10.1111/aos.14304. View

Pichi F, Aggarwal K, Neri P, Salvetti P, Lembo A, Nucci P . Choroidal biomarkers. Indian J Ophthalmol. 2018; 66(12):1716-1726. PMC: 6256910. DOI: 10.4103/ijo.IJO_893_18. View

Weiter J, Delori F, Wing G, FITCH K . Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci. 1986; 27(2):145-52. View

10.

Inomata H, Sakamoto T . Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus. Curr Eye Res. 1990; 9 Suppl:35-40. DOI: 10.3109/02713689008999417. View

11.

Horie S, Takase H, Yoshida T, Ohno-Matsui K . Sympathetic ophthalmia in eye with pathologic myopia. Am J Ophthalmol Case Rep. 2022; 25:101295. PMC: 8801987. DOI: 10.1016/j.ajoc.2022.101295. View

12.

Read R, Holland G, RAO N, Tabbara K, Ohno S, Arellanes-Garcia L . Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001; 131(5):647-52. DOI: 10.1016/s0002-9394(01)00925-4. View

13.

Ikuno Y, Kawaguchi K, Nouchi T, Yasuno Y . Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci. 2009; 51(4):2173-6. DOI: 10.1167/iovs.09-4383. View

14.

OKeefe G, Rao N . Vogt-Koyanagi-Harada disease. Surv Ophthalmol. 2016; 62(1):1-25. DOI: 10.1016/j.survophthal.2016.05.002. View

15.

Wu Q, Chen Q, Lin B, Huang S, Wang Y, Zhang L . Relationships among retinal/choroidal thickness, retinal microvascular network and visual field in high myopia. Acta Ophthalmol. 2020; 98(6):e709-e714. DOI: 10.1111/aos.14372. View

16.

Okada T, Sakamoto T, Ishibashi T, Inomata H . Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site. Graefes Arch Clin Exp Ophthalmol. 1996; 234(6):359-63. DOI: 10.1007/BF00190711. View